XTLB
XTL Biopharmaceuticals
XTLB
XTLB
4 hedge funds and large institutions have $2M invested in XTL Biopharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
UBS Group
Zurich,
Switzerland
|
$3K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$1K |
Top Sellers
| 1 |
SM
1
Sabby Management
Miami Beach,
Florida
|
$1.79M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $1.79M | 1,149,886 | -1,095 | -0.1% |
|
2
Invesco
Atlanta,
Georgia
| $203K | 129,811 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $3K | 1,704 | +1,704 | New |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| $1K | 400 | +400 | New |
|
5
Morgan Stanley
New York
| – | – | -5 | Closed |
|